Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem vs Cefepime in Pediatric cUTI
NCT01110408Phase 3Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of doripenem in complicated urinary tract infection (cUTI), pyelonephritis, sponsored by Janssen Pharmaceutical. Started Dec 2010; status: terminated.
02
Drugs
doripenem
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on NCT01110408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01110408.